CN101032619A - Liquid medicine to be taken orally for curing primary hypertension and the preparing method - Google Patents
Liquid medicine to be taken orally for curing primary hypertension and the preparing method Download PDFInfo
- Publication number
- CN101032619A CN101032619A CN 200710017405 CN200710017405A CN101032619A CN 101032619 A CN101032619 A CN 101032619A CN 200710017405 CN200710017405 CN 200710017405 CN 200710017405 A CN200710017405 A CN 200710017405A CN 101032619 A CN101032619 A CN 101032619A
- Authority
- CN
- China
- Prior art keywords
- radix
- percentage
- weight
- rhizoma
- parched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 239000007788 liquid Substances 0.000 title claims abstract description 24
- 208000007530 Essential hypertension Diseases 0.000 title claims abstract description 17
- 238000000034 method Methods 0.000 title description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 11
- 210000000582 semen Anatomy 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000012141 concentrate Substances 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 16
- 239000012467 final product Substances 0.000 claims description 16
- 238000011282 treatment Methods 0.000 claims description 15
- 241000756943 Codonopsis Species 0.000 claims description 12
- 241000628997 Flos Species 0.000 claims description 12
- 241000237903 Hirudo Species 0.000 claims description 12
- 239000009636 Huang Qi Substances 0.000 claims description 12
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 8
- 229940126701 oral medication Drugs 0.000 claims description 3
- 239000010135 fructus aurantii immaturus Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 12
- 208000005392 Spasm Diseases 0.000 abstract description 5
- 210000001367 artery Anatomy 0.000 abstract description 5
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 230000008327 renal blood flow Effects 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000001954 sterilising effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 22
- 239000008280 blood Substances 0.000 description 22
- 230000017531 blood circulation Effects 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 8
- 206010020772 Hypertension Diseases 0.000 description 7
- 239000004480 active ingredient Substances 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 239000003087 receptor blocking agent Substances 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- 240000005373 Panax quinquefolius Species 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000003748 differential diagnosis Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 101710129690 Angiotensin-converting enzyme inhibitor Proteins 0.000 description 1
- 101710086378 Bradykinin-potentiating and C-type natriuretic peptides Proteins 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 229940097420 Diuretic Drugs 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000004987 nonapoptotic effect Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 230000003235 vasospasmolytic effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses oral medicine liquid for treating primary hypertension and its preparation process. The oral medicine liquid has active components prepared with roasted astragalus root, Dangshen, fried white atractylodes rhizome, dried old orange peel, angelica and other 18 kinds of Chinese medicinal materials, and is prepared through twice decoctions, concentrating decoction, bottling and sterilizing. It can eliminate repeated spasm of body's small arteries, eliminate stasis matter and restore renal blood flow to stabilize blood pressure. It has convenient taking, no recurrence, no toxic side effect and other advantages. The present invention also discloses the new application of the medicine liquid in preparing medicine.
Description
Technical field
The invention belongs to medical technical field, be specifically related to a kind of oral liquid medicine for the treatment of essential hypertension, the preparation method that the invention still further relates to this medicinal liquid with and application in the preparation oral liquid medicine.
Background technology
Essential hypertension, it is the general chronic disease sum total disease of feature that doctor trained in Western medicine is thought to increase with systemic arterial pressure, spasm and the pathological changes prolonged and repeated owing to the whole body small artery cause small artery to present luminal stenosis, the necrosis of tube wall fiber-like, and differential diagnosis in tcm thinks that this disease is three types, " liver " sun is the Sheng type partially, " liver ", " kidney " YIN-deficiency type, deficiency of both YIN and YANG type.Arteriolar pathological changes can make the yin or yang excess inclined to one side void of internal organs in surrounding tissue and the organ pipe, finally causes and organizes organ pipe hypoxic-ischemic and damage, if malpractice, persistent hypertension can cause heart and brain kidney vascular lesion or accident, causes death.
In the treatment of essential hypertension, doctor trained in Western medicine is often with the B receptor blocking agent, the a receptor blocking agent, the aB receptor blocking agent, calcium antagonist and angiotensin converting enzyme inhibitor, diuretic, the peripheral vasodilation agent is a therapy, although adopting single choosing or all kinds of antihypertensive drugs of use in conjunction treats, but can only make the blood pressure of Most patients controlled, and very big, and rate height repeatedly to the infringement of internal organs, the traditional Chinese medical science is general to be adopted with flat " liver " YANG hyperactivity suppressing, nourishing YIN for attracting YANG, the oral medicinal herb method treatment of warming YANG nourishing YIN, but in present medicine, it is slow to exist curative effect, DeGrain, the high shortcoming of rate repeatedly.
Summary of the invention
The object of the present invention is to provide a kind of oral liquid medicine for the treatment of essential hypertension, it is slow to have solved existing treatment hypertension drug curative effect, the big and high shortcoming of rate repeatedly of side effect.
Another object of the present invention is to provide the preparation method of above-mentioned oral liquid medicine.
The present invention also aims to provide the application of above-mentioned oral liquid medicine in the preparation endo-medicine.
The technical solution adopted in the present invention is, the oral liquid medicine of treatment essential hypertension, form by active ingredient, active ingredient consist of Radix Astragali Preparata 3.9%-4.9%, Radix Codonopsis 3.9%-4.9%, Rhizoma Atractylodis Macrocephalae (parched) 4.68%-5.68%, Pericarpium Citri Reticulatae 3.9%-4.9%, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 3.9%-4.9%, Radix Angelicae Sinensis 4.68%-5.68%, Fructus Crataegi 3.9%-4.9%, Radix Bupleuri 3.9%-4.9% fries long-pending real 3.9%-4.9%, fries Cortex Magnoliae Officinalis 3.9%-4.9%, Rhizoma Zingiberis Preparatum 3.9%-4.9%, Poria 3.9%-4.9%, rhizoma sparganic 3.9%-4.9%, Rhizoma Curcumae 3.9%-4.9%, Hirudo 3.9%-4.9%, Radix Et Rhizoma Rhei 8.19%-9.19%, Semen Arecae 6.85%-7.85%, Semen Persicae 2.34%-3.34%, Flos Carthami 3.9%-4.9%, Radix Cyathulae 9.75%-10.75%, Cortex Eucommiae (parched) 3.9%-4.9%, Radix Rehmanniae Preparata 3.9%-4.9%, Radix Glycyrrhizae Preparata 2.34%-3.34%, the total amount of active ingredient is 100%.
Another technical scheme of the present invention is, the preparation method of above-mentioned treatment essential hypertension oral liquid medicine, may further comprise the steps: be the Radix Astragali Preparata of 3.9%-4.9% with percentage by weight and get Radix Codonopsis 3.9%-4.9% by weight percentage, Rhizoma Atractylodis Macrocephalae (parched) 4.68%-5.68%, Pericarpium Citri Reticulatae 3.9%-4.9%, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 3.9%-4.9%, Radix Angelicae Sinensis 4.68%-5.68%, Fructus Crataegi 3.9%-4.9%, Radix Bupleuri 3.9%-4.9%, fry long-pending real 3.9%-4.9%, fry Cortex Magnoliae Officinalis 3.9%-4.9%, Rhizoma Zingiberis Preparatum 3.9%-4.9%, Poria 3.9%-4.9%, rhizoma sparganic 3.9%-4.9%, Rhizoma Curcumae 3.9%-4.9%, Hirudo 3.9%-4.9%, Radix Et Rhizoma Rhei 8.19%-9.19%, Semen Arecae 6.85%-7.85%, Semen Persicae 2.34%-3.34%, Flos Carthami 3.9%-4.9%, Radix Cyathulae 9.75%-10.75%, Cortex Eucommiae (parched) 3.9%-4.9%, Radix Rehmanniae Preparata 3.9%-4.9%, Radix Glycyrrhizae Preparata 2.34%-3.34%.Add water and decocted in right amount 1-2 hour, filtering residue concentrates, and solution to be concentrated approximately get final product to 200 milliliters, adds water again and decocts in right amount 1-2 hour, filtering residue, concentrates, and solution to be concentrated approximately get final product to 200 milliliters, and with twice concentrated medicament mixing, stirring promptly then.
The technical solution adopted in the present invention also comprises:
Above-mentioned oral liquid medicine is being controlled the application that is equipped with in the essential hypertension oral drugs.
The present invention treats the oral liquid medicine of essential hypertension, be with temperature compensation human body day after tomorrow biochemical insufficient medicine be main formula, add the removing blood stasis eliminating stagnation again, removing blood stasis is invigorated blood circulation, the intestinal stasis relieving of regulating the flow of vital energy, nourishing liver and kidney, the medicine of warm promoting blood circulation is prescription.Adopt the pharmaceutical methods of decocting in water.Hyperpietic to three phases of first phase second phase uses the oral drugs method, and blood pressure is reduced to normally in a short time.Through clinical routine patient treatments up to a hundred are had good effect, characteristics such as instant effect has no side effect, and pharmaceutical methods is simple, cure rate reaches more than 90%.
The specific embodiment
Below in that the present invention is described in detail in conjunction with specific embodiments.
The oral liquid medicine of treatment essential hypertension of the present invention is made up of active ingredient, and its ratio is that active ingredient is 100%, wherein, active ingredient consists of Radix Astragali Preparata 3.9%-4.9%, Radix Codonopsis 3.9%-4.9%, Rhizoma Atractylodis Macrocephalae (parched) 4.68%-5.68%, Pericarpium Citri Reticulatae 3.9%-4.9%, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 3.9%-4.9%, Radix Angelicae Sinensis 4.68%-5.68%, Fructus Crataegi 3.9%-4.9%, Radix Bupleuri 3.9%-4.9% fries long-pending real 3.9%-4.9%, fry Cortex Magnoliae Officinalis 3.9%-4.9%, Rhizoma Zingiberis Preparatum 3.9%-4.9%, Poria 3.9%-4.9%, rhizoma sparganic 3.9%-4.9%, Rhizoma Curcumae 3.9%-4.9%, Hirudo 3.9%-4.9%, Radix Et Rhizoma Rhei 8.19%-9.19%, Semen Arecae 6.85%-7.85%, Semen Persicae 2.34%-3.34%, Flos Carthami 3.9%-4.9%, Radix Cyathulae 9.75%-10.75%, Cortex Eucommiae (parched) 3.9%-4.9%, Radix Rehmanniae Preparata 3.9%-4.9%, Radix Glycyrrhizae Preparata 2.34%-3.34%.
Wherein, Radix Astragali Preparata has the liver glycogen of preventing to be reduced, and liver-protective effect is arranged; can make coronary vasodilator, the renal blood vessels expansion has heart tonifying diuresis and hypotensive activity; can strengthen capillary resistance, blood vessel dilating, it is capable to improve blood; non-viable non-apoptotic cell is rejuvenated, and the Radix Codonopsis invigorating the spleen and replenishing QI has excitation to nervous system; energy enhancing body resistance; stimulate increase hematochrome and erythrocyte by spleen, make peripheral vasodilation, bring high blood pressure down.The Rhizoma Atractylodis Macrocephalae (parched) the spleen strengthening and damp drying can promote gastrointestinal secretion, and blood sugar lowering is arranged, blood circulation promoting and diuresis.Chinese angelica blood supplementing, promoting blood circulation and detoxication, loosening bowel to relieve constipation.Pericarpium Citri Reticulatae regulate the flow of vital energy appetizing, soothing liver-QI, reduce phlegm, the resolving depression eliminating stagnation.The Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) stopping nausea and vomiting by lowering the adverse flow of QI, drying dampness to eliminate phlegm, Fructus Crataegi can increase ferment in the stomach, and facilitating digestion has the cardiac insufficiency of improvement, blood sugar lowering, the effect that brings high blood pressure down, Radix Bupleuri dispersing the stagnated live-QI to relieve the stagnation of QI.Fry long-pending real dispelling the stagnated QI and reduce phlegm therapeutic method to keep the adverse QI flowing downwards relieving constipation.Fry the Cortex Magnoliae Officinalis regulating QI to expel dampness, lowering the adverse QI to relieve asthma.The Rhizoma Zingiberis Preparatum warming spleen and stomach for dispelling cold, warming the meridian for stopping bleeding, the medicine of promotion is arranged, and heat is diffusing in vivo, reaches vasospasmolytic effect.Poria has diuresis, can promote electrolytical discharges such as sodium potassium and chlorine.The promoting the circulation of blood of rhizoma sparganic dispelling the stagnated QI.Rhizoma Curcumae circulation of qi promoting dissipating blood stasis.Hirudo has blood coagulation resisting function, can stop thrombin action in fibrin after going into blood, doubts knot thereby delay blood, also can lower the adhesion strength of blood, alleviates the spasm of arterial wall, with the alleviating hypertension symptom.The Radix Et Rhizoma Rhei removing blood stasis is invigorated blood circulation, and emodin can make the intestinal wall secretion increase, and impels blood stasis and stagnant gas to discharge from stool.The Semen Arecae regulating qi-flowing for activating stagnancy, promoting the circulation of QI to induce diuresis.The Semen Persicae removing blood stasis, loosening bowel to relieve constipation.The Flos Carthami blood circulation promoting and blood stasis dispelling.The Radix Cyathulae blood circulation promoting and blood stasis dispelling, invigorating the liver and kidney now, conducting blood to flow downwards, and diuresis and hypotensive activity are arranged.Cortex Eucommiae (parched) has the effect of invigorating the liver and kidney, and can reduce the absorption of cholesterol and bring high blood pressure down.Radix Rehmanniae Preparata the moon is now enriched blood.The Radix Glycyrrhizae Preparata invigorating the spleen and replenishing QI, coordinating the actions of various ingredients in a prescription, total side entirely that sees is according to the differential diagnosis in tcm theory.The reasonable mixture ratio of this prescription components selection and content, the pathogenesis that hits, above-mentioned all flavor medicines share, with the removing blood stasis eliminating stagnation, removing blood stasis is invigorated blood circulation, the intestinal stasis relieving of regulating the flow of vital energy, invigorating the liver and kidney now, the prescription of warm promoting blood circulation increases the effect of the temperature compensation human body biochemical insufficient main formula day after tomorrow, effectively eliminate the prolonged and repeated spasm of whole body small artery, remove the stasis object in the tube chamber, repair the tube wall of necrosis and reply kidney normal blood flow amount, eliminate patient's slight illness.
The preparation method of above-mentioned treatment essential hypertension oral liquid medicine, may further comprise the steps: be the Radix Astragali Preparata of 3.9%-4.9% with percentage by weight and get Radix Codonopsis 3.9%-4.9% by weight percentage, Rhizoma Atractylodis Macrocephalae (parched) 4.68%-5.68%, Pericarpium Citri Reticulatae 3.9%-4.9%, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 3.9%-4.9%, Radix Angelicae Sinensis 4.68%-5.68%, Fructus Crataegi 3.9%-4.9%, Radix Bupleuri 3.9%-4.9%, fry long-pending real 3.9%-4.9%, fry Cortex Magnoliae Officinalis 3.9%-4.9%, Rhizoma Zingiberis Preparatum 3.9%-4.9%, Poria 3.9%-4.9%, rhizoma sparganic 3.9%-4.9%, Rhizoma Curcumae 3.9%-4.9%, Hirudo 3.9%-4.9%, Radix Et Rhizoma Rhei 8.19%-9.19%, Semen Arecae 6.85%-7.85%, Semen Persicae 2.34%-3.34%, Flos Carthami 3.9%-4.9%, Radix Cyathulae 9.75%-10.75%, Cortex Eucommiae (parched) 3.9%-4.9%, Radix Rehmanniae Preparata 3.9%-4.9%, Radix Glycyrrhizae Preparata 2.34%-3.34%, adding water decocted 1-2 hour in right amount, filtering residue concentrates, and solution to be concentrated approximately gets final product to 200 milliliters, adding water again decocted 1-2 hour in right amount, filtering residue concentrates, and solution to be concentrated approximately gets final product to 200 milliliters, then twice concentrated medicament mixed, stir promptly.
Embodiment 1
With the Radix Astragali Preparata of 10g (percentage by weight is 3.9%) with get Radix Codonopsis 10g (percentage by weight is 3.9%) by weight percentage, Rhizoma Atractylodis Macrocephalae (parched) 10g (percentage by weight is 4.68%), Pericarpium Citri Reticulatae 10g (percentage by weight is 3.9%), Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 10g (percentage by weight is 3.9%), Radix Angelicae Sinensis 12g (percentage by weight is 4.68%), Fructus Crataegi 10g (percentage by weight is 3.9%), Radix Bupleuri 10g (percentage by weight is 3.9%), fry long-pending real 10g (percentage by weight is 3.9%), fry Cortex Magnoliae Officinalis 10g (percentage by weight is 3.9%), Rhizoma Zingiberis Preparatum 10g (percentage by weight is 3.9%), Poria 10g (percentage by weight is 3.9%), rhizoma sparganic 10g (percentage by weight is 3.9%), Rhizoma Curcumae 10g (percentage by weight is 3.9%), Hirudo 10g (percentage by weight is 3.9%), Radix Et Rhizoma Rhei 21g (percentage by weight is 8.19%), Semen Arecae 15g (percentage by weight is 6.85), Semen Persicae 6g (percentage by weight is 2.34%), Flos Carthami 10g (percentage by weight is 3.9%), Radix Cyathulae 25g (percentage by weight is 9.75%), Cortex Eucommiae (parched) 10g (percentage by weight is 3.9%), Radix Rehmanniae Preparata 10g (percentage by weight is 3.9%), Radix Glycyrrhizae Preparata 6g (percentage by weight is 2.34%) adds water and decocted filtering residue in right amount 1-2 hour, concentrate, solution to be concentrated approximately gets final product to 200 milliliters, adds water again and decocts filtering residue in right amount 1-2 hour, concentrate, solution to be concentrated approximately gets final product to 200 milliliters, then twice concentrated medicament is mixed, and stirs promptly.
Embodiment 2
With the Radix Astragali Preparata of 12g (percentage by weight is 5.04%) with get Radix Codonopsis 12g (percentage by weight is 5.04%) Rhizoma Atractylodis Macrocephalae (parched) 10g (percentage by weight is 4.2%) by weight percentage, Pericarpium Citri Reticulatae 8g (percentage by weight 3.36%), Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 8g (percentage by weight 3.36%), Radix Angelicae Sinensis 15g (percentage by weight is 6.3%), Fructus Crataegi 10g (percentage by weight is 4.2%), Radix Bupleuri 8g (percentage by weight 3.36%), fry long-pending real 8g (percentage by weight 3.36%), fry Cortex Magnoliae Officinalis 8g (percentage by weight 3.36%), Rhizoma Zingiberis Preparatum 10g (percentage by weight is 4.2%), Poria 8g (percentage by weight 3.36%), rhizoma sparganic 8g (percentage by weight 3.36%), Rhizoma Curcumae 8g (percentage by weight 3.36%), Hirudo 12g (percentage by weight is 5.04%), Radix Et Rhizoma Rhei 18g (percentage by weight is 7.56%), Semen Arecae 12g (percentage by weight is 5.04%), (percentage by weight is (2.1%) to Semen Persicae 5g, Flos Carthami 8g (percentage by weight 3.36%), Radix Cyathulae 22g (percentage by weight is 9.24%), Cortex Eucommiae (parched) 10g (percentage by weight is 4.2%), Radix Rehmanniae Preparata 10g (percentage by weight is 4.2%), Radix Glycyrrhizae Preparata 6g (percentage by weight is 2.52%), adding water decocted 1-2 hour in right amount, filtering residue concentrates, and solution to be concentrated approximately gets final product to 200 milliliters, adding water again decocted 1-2 hour in right amount, filtering residue concentrates, and solution to be concentrated approximately gets final product to 200 milliliters, then twice concentrated medicament mixed, stir promptly.
Embodiment 3
With the Radix Astragali Preparata of 15g (percentage by weight is 6.9%) with get Radix Codonopsis 15g (percentage by weight is 6.9%) by weight percentage, Rhizoma Atractylodis Macrocephalae (parched) 10g (percentage by weight is 4.6%), Pericarpium Citri Reticulatae 6g (percentage by weight is 2.76%), Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 6g (percentage by weight is 2.76%-), Radix Angelicae Sinensis 10g (percentage by weight is 4.6%), Fructus Crataegi 8g (percentage by weight is 3.68%), Radix Bupleuri 6g (percentage by weight is 2.76%), fry long-pending real 6g (percentage by weight is 2.76%), fry Cortex Magnoliae Officinalis 6g (percentage by weight is 2.76%), Rhizoma Zingiberis Preparatum 10g (percentage by weight is 4.6%), Poria 10g (percentage by weight is 4.6%), rhizoma sparganic 8g (percentage by weight is 3.68%), Rhizoma Curcumae 8g (percentage by weight is 3.68%), Hirudo 10g (percentage by weight is 4.6%), Radix Et Rhizoma Rhei 15g (percentage by weight is 6.9%), Semen Arecae 10g (percentage by weight is 4.6%), Semen Persicae 5g (percentage by weight is 2.3%), Flos Carthami 8g (percentage by weight is 3.68%), Radix Cyathulae 20g (percentage by weight is 5.2%), Cortex Eucommiae (parched) 10g (percentage by weight is 4.6%), Radix Rehmanniae Preparata 10g (percentage by weight is 4.6%), Radix Glycyrrhizae Preparata 5g (percentage by weight is 2.3%) adds water and decocted filtering residue in right amount 1-2 hour, concentrate, solution to be concentrated approximately gets final product to 200 milliliters, adds water again and decocts filtering residue in right amount 1-2 hour, concentrate, solution to be concentrated approximately gets final product to 200 milliliters, then twice concentrated medicament is mixed, and stirs promptly.
Embodiment 4
With the Radix Astragali Preparata of 17g (percentage by weight is 8.33%) with get Radix Codonopsis 15g (percentage by weight is 7.35%) by weight percentage, Rhizoma Atractylodis Macrocephalae (parched) 15g (percentage by weight is 7.35%), Pericarpium Citri Reticulatae 6g (percentage by weight is 2.95%), Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 6g (percentage by weight is 2.95%), Radix Angelicae Sinensis 12g (percentage by weight is 5.88%), Fructus Crataegi 10g (percentage by weight is 4.9%), Radix Bupleuri 6g (percentage by weight is 2.95%), fry long-pending real 6g (percentage by weight is 2.95%), fry Cortex Magnoliae Officinalis 6g (percentage by weight is 2.95%), Rhizoma Zingiberis Preparatum 8g (percentage by weight is 3.92%), Poria 8g (percentage by weight is 3.92%), rhizoma sparganic 6g (percentage by weight is 2.95%), Rhizoma Curcumae 6g (percentage by weight is 2.95%), Hirudo 15g (percentage by weight is 7.35%), Radix Et Rhizoma Rhei 10g (percentage by weight is 4.9%), Semen Arecae 6g (percentage by weight is 2.95%), Semen Persicae 5g (percentage by weight 2.45%), Flos Carthami 6g (percentage by weight is 2.95%), Radix Cyathulae 15g (percentage by weight is 7.35%), Cortex Eucommiae (parched) 8g (percentage by weight is 3.92%), Radix Rehmanniae Preparata 8g (percentage by weight is 3.92%), Radix Glycyrrhizae Preparata 5g (percentage by weight 2.45%) adds water and decocted filtering residue in right amount 1-2 hour, concentrate, solution to be concentrated approximately gets final product to 200 milliliters, adds water again and decocts filtering residue in right amount 1-2 hour, concentrate, solution to be concentrated approximately gets final product to 200 milliliters, then twice concentrated medicament is mixed, and stirs promptly.
Embodiment 5
With the Radix Astragali Preparata of 10g (percentage by weight is 5.3%) with get Radix Codonopsis 10g (percentage by weight is 5.3%) by weight percentage, tip of a twig Rhizoma Atractylodis Macrocephalae 12g (percentage by weight is 6.36%), Pericarpium Citri Reticulatae 6g (percentage by weight is 3.18%), Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 6g (percentage by weight is 3.18%), Radix Angelicae Sinensis 12g (percentage by weight is 6.36%), Fructus Crataegi 10g (percentage by weight is 5.3%), Radix Bupleuri 6g (percentage by weight is 3.18%), fry long-pending real 6g (percentage by weight is 3.18%), fry Cortex Magnoliae Officinalis 6g (percentage by weight is 3.18%), Rhizoma Zingiberis Preparatum 10g (percentage by weight is 5.3%), Poria 10g (percentage by weight is 5.3%), rhizoma sparganic 6g (percentage by weight is 3.18%), Rhizoma Curcumae 6g (percentage by weight is 3.18%), Hirudo 10g (percentage by weight is 5.3%), Radix Et Rhizoma Rhei 10g (percentage by weight is 5.3%), Semen Arecae 8g (percentage by weight is 4.24%), Semen Persicae 5g (percentage by weight is 2.65%), Flos Carthami 6g (percentage by weight is 3.18%), Radix Cyathulae 15g (percentage by weight is 7.95%), Cortex Eucommiae (parched) 6g (percentage by weight is 3.18%), Radix Rehmanniae Preparata 6g (percentage by weight is 3.18%), Radix Glycyrrhizae Preparata 5g (percentage by weight is 2.65%) adds water and decocted filtering residue in right amount 1-2 hour, concentrate, solution to be concentrated approximately gets final product to 200 milliliters, adds water again and decocts filtering residue in right amount 1-2 hour, concentrate, solution to be concentrated approximately gets final product to 200 milliliters, then twice concentrated medicament is mixed, and stirs promptly.
Using method: oral, three times on the one, a 100-150 milliliter, warm taking medicine after meal.
Indication: liver-yang is the Sheng type partially, liver-kidney yin deficiency, the diseases such as hypertension that the deficiency of both YIN and YANG type causes.
Medicine of the present invention is an oral liquid medicine, with the removing blood stasis eliminating stagnation, removing blood stasis is invigorated blood circulation, the intestinal stasis relieving of regulating the flow of vital energy, nourishing the liver and kidney, temperature promoting blood circulation and the temperature compensation human body biochemical insufficient method day after tomorrow, eliminate the prolonged and repeated spasm of whole body small artery, remove the stasis object in the tube chamber, reach and repair downright bad tube wall, reply the renal blood flow amount, reply normotensive effect.Easy to use, cheap, through clinical routine patient treatments up to a hundred are had no side effect, in treatment essential hypertension example, instant effect, short treating period, not repeatedly, cure rate reaches more than 90%.
The invention still further relates to the application of this oral liquid in preparation essential hypertension endo-medicine, essence for a better understanding of the present invention, the data that is used for clinical diagnosis and treatment below with oral liquid of the present invention is with the therapeutic effect that proves this medicine and its new purposes in pharmaceutical field is described.
Case 1
Jia Guangyin, man, 68 years old now, be that Qingyang, Gansu Province mayor celebrates the oil field veteran worker, suffered from hypertension 10 years, the Changzhi is weary imitates, in the diagnosis and treatment of going back home in 1996, patient's dizziness, a pain, cardiopalmus, uncomfortable in chest, top-heavy, the row step is unstable, feverish sensation in the palms and soles, dryness of the mouth and throat, the lumbago lower limb is soft, fear of cold, polyuria at night, pale tongue, no fur, pulse condition stringy and thready pulse, blood pressure 250mmHg/160mmHg, through with medicinal liquid of the present invention treatment, every day potion, three times on the one, one time 150 milliliters, obey three doses after, blood pressure is reduced to 230mmHg/140mmHg, all diseases alleviate, and stool is rushed down purulent secretion down, behind 15 doses of clothes, blood pressure is reduced to 140mmHg/95mmHg, because of advanced in years, withdraws medicinal liquid, follow up a case by regular visits to after 10 years, blood pressure remains on 140mmHg/95mmHg always, and all disease tools disappear.
This kind hypertension case is cured 50 many cases altogether, and cure rate reaches 100%.
Case 2
The Jia Xiangruo wife, the woman lives Shi Lipu village, Zichang County Luan Jiaping township, 63 years old now, suffered from hypertension 8 years, examine May 17 calendar year 2001, blood pressure 210mmHg/140mmHg suffers from often giddy, headache, being irritable and irascible, soreness of waist and knee joint, insomnia and dreamful sleep, numb limbs and tense tendons, dysphoria with feverish sensation in the chest palms and soles, red tongue, tongue Pu Bai, stringy and thready pulse was once taken multiple Chinese medicine and western medicine antihypertensive drugs, effect is undesirable, through with medicinal liquid of the present invention treatment, every day potion, three times on the one, one time 150 milliliters, obey three doses after stool rush down down purulent secretion, all diseases alleviate, and blood pressure is reduced to 180mmHg/120mmHg/, behind 12 doses of clothes, blood pressure is reduced to 140mmHg/90mmHg, withdraws medicinal liquid, follows up a case by regular visits to blood pressure after 5 years and does not raise again.
This kind hypertension case is cured 42 examples altogether, and cure rate reaches 100%.
Case 3
Feng Xiaoling, woman, 58 years old, suffered from hypertension 5 years, and now lived Gansu Province's Zhangye, in the diagnosis and treatment of going home in 2003, patient's headache, agitation, irritability, bitter taste, conjunctival congestion, insomnia sometimes, red tongue, tongue is broad yellow, the pulse condition stringy and rapid pulse, blood pressure 150mmHg/110mmHg once obeyed multiple Chinese and western drugs treatment, poor effect, through with medicinal liquid of the present invention treatment, every day potion, three times on the one, one time 150 milliliters, obey three doses after, stool is rushed down down purulent secretion, all diseases alleviate, and blood pressure is reduced to 130mmHg/105mmHg, continue and obey 8 doses, all diseases disappear, and blood pressure is reduced to 120mmHg/80mmHg, follow up a case by regular visits to blood pressure after 2 years and do not raise again.
This kind hypertension case is cured 60 many cases altogether, and cure rate reaches 95%.
Claims (3)
1, a kind of oral liquid medicine for the treatment of essential hypertension, form by active component, consisting of of described active component: Radix Astragali Preparata 3.9%-4.9%, Radix Codonopsis 3.9%-4.9%, Rhizoma Atractylodis Macrocephalae (parched) 4.68%-5.68%, Pericarpium Citri Reticulatae 3.9%-4.9%, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 3.9%-4.9%, Radix Angelicae Sinensis 4.68%-5.68%, Fructus Crataegi 3.9%-4.9%, Radix Bupleuri 3.9%-4.9%, Fructus Aurantii Immaturus (parched) 3.9%-4.9%, fry Cortex Magnoliae Officinalis 3.9%-4.9%, Rhizoma Zingiberis Preparatum 3.9%-4.9%, Poria 3.9%-4.9%, rhizoma sparganic 3.9%-4.9%, Rhizoma Curcumae 3.9%-4.9%, Hirudo 3.9%-4.9%, Radix Et Rhizoma Rhei 8.19%-9.19%, Semen Arecae 6.85%-7.85%, Semen Persicae 2.34%-3.34%, Flos Carthami 3.9%-4.9%, Radix Cyathulae 9.75%-10.75%, Cortex Eucommiae (parched) 3.9%-4.9%, Radix Rehmanniae Preparata 3.9%-4.9%, Radix Glycyrrhizae Preparata 2.34%-3.34%, the total amount of active component is 100%.
2, a kind of preparation method according to the described oral liquid medicine of claim 1, it is characterized in that, may further comprise the steps: be the Radix Astragali Preparata of 3.9%-4.9% with percentage by weight and get Radix Codonopsis 3.9%-4.9% by weight percentage, Rhizoma Atractylodis Macrocephalae (parched) 4.68%-5.68%, Pericarpium Citri Reticulatae 3.9%-4.9%, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 3.9%-4.9%, Radix Angelicae Sinensis 4.68%-5.68%, Fructus Crataegi 3.9%-4.9%, Radix Bupleuri 3.9%-4.9%, Fructus Aurantii Immaturus (parched) 3.9%-4.9%, fry Cortex Magnoliae Officinalis 3.9%-4.9%, Rhizoma Zingiberis Preparatum 3.9%-4.9%, Poria 3.9%-4.9%, rhizoma sparganic 3.9%-4.9%, Rhizoma Curcumae 3.9%-4.9%, Hirudo 3.9%-4.9%, Radix Et Rhizoma Rhei 8.19%-9.19%, Semen Arecae 6.85%-7.85%, Semen Persicae 2.34%-3.34%, Flos Carthami 3.9%-4.9%, Radix Cyathulae 9.75%-10.75%, Cortex Eucommiae (parched) 3.9%-4.9%, Radix Rehmanniae Preparata 3.9%-4.9%, Radix Glycyrrhizae Preparata 2.34%-3.34%, add water and decoct 1-2 hour filtering residue in right amount, concentrate, solution to be concentrated approximately gets final product to 200 milliliters, adding water again decocted 1-2 hour in right amount, filtering residue, concentrate, solution to be concentrated approximately gets final product to 200 milliliters, then twice medicinal liquid mixed, stir promptly.
3, the application of oral liquid medicine according to claim 1 in preparation essential hypertension oral drugs.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710017405A CN101032619B (en) | 2007-02-02 | 2007-02-02 | Liquid medicine to be taken orally for curing primary hypertension and the preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200710017405A CN101032619B (en) | 2007-02-02 | 2007-02-02 | Liquid medicine to be taken orally for curing primary hypertension and the preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101032619A true CN101032619A (en) | 2007-09-12 |
| CN101032619B CN101032619B (en) | 2010-05-19 |
Family
ID=38729485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200710017405A Expired - Fee Related CN101032619B (en) | 2007-02-02 | 2007-02-02 | Liquid medicine to be taken orally for curing primary hypertension and the preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101032619B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8680053B2 (en) | 2008-07-09 | 2014-03-25 | Quercegen Pharmaceuticals Llc | Improving renal function with quercetin-containing compositions |
| CN105311307A (en) * | 2015-11-27 | 2016-02-10 | 劳冠阳 | Medicine for treating hypertension |
| CN105816711A (en) * | 2016-04-15 | 2016-08-03 | 宁波优美科新材料有限公司 | Medicine for treating dizziness due to wind |
| CN105832934A (en) * | 2016-06-12 | 2016-08-10 | 宋兴刚 | Traditional Chinese medicine for treating hypertension |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100342891C (en) * | 2005-05-20 | 2007-10-17 | 刘丙乾 | Medicine composition for hypertension and its preparation thereof |
| CN1814168A (en) * | 2005-12-22 | 2006-08-09 | 陈宝贵 | Medicine for treating hypertension and preparing method thereof |
-
2007
- 2007-02-02 CN CN200710017405A patent/CN101032619B/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8680053B2 (en) | 2008-07-09 | 2014-03-25 | Quercegen Pharmaceuticals Llc | Improving renal function with quercetin-containing compositions |
| CN105311307A (en) * | 2015-11-27 | 2016-02-10 | 劳冠阳 | Medicine for treating hypertension |
| CN105816711A (en) * | 2016-04-15 | 2016-08-03 | 宁波优美科新材料有限公司 | Medicine for treating dizziness due to wind |
| CN105832934A (en) * | 2016-06-12 | 2016-08-10 | 宋兴刚 | Traditional Chinese medicine for treating hypertension |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101032619B (en) | 2010-05-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100339123C (en) | Traditional Chinese medicine liquor and preparation method thereof | |
| CN103301412A (en) | Traditional Chinese medicine composition for treating alcoholic liver | |
| CN102512630B (en) | Traditional Chinese medicine composition for treating gallbladder calculus | |
| CN101502582A (en) | Composition for eliminating stagnation and promoting lactation and preparation method thereof | |
| CN105056124A (en) | Medicine for treating hypertension and diabetes | |
| CN101041046A (en) | Chinese traditional medicine compound took orally for treating morning diarrhea | |
| CN102512632B (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN101032619B (en) | Liquid medicine to be taken orally for curing primary hypertension and the preparing method | |
| CN100488558C (en) | Medicament for treating heart disease and preparation process thereof | |
| CN102908425B (en) | Medicine for treating heart diseases and thick blood lipid and preparation method of the medicine | |
| CN102228648B (en) | Chinese medicinal composition for treating icterohepatitis | |
| CN103007217A (en) | Chinese medicinal composition for treating hypotension | |
| CN102416146A (en) | Traditional Chinese medicine composition for treating amenorrhea | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN104548037A (en) | Traditional Chinese medicine composition for treating chronic eczema | |
| CN104758439A (en) | Traditional Chinese medicine composition for treating thoracic obstruction | |
| CN102274442B (en) | Deer bone wine for treating arthralgia syndrome and preparation method and application thereof | |
| CN100512872C (en) | Chinese medicines composition took orally for treating hyperlipemia | |
| CN101693095A (en) | Traditional Chinese medicine preparation for treating cirrhosis and liver ascites | |
| CN106310082A (en) | Kidney-tonifying traditional Chinese medicine composition and preparation method thereof | |
| CN105250903A (en) | Traditional Chinese medicine physiotherapeutic liquid for treating numbness of limbs and preparation method of traditional Chinese medicine physiotherapeutic liquid | |
| CN104784649A (en) | Traditional Chinese medicine decoction for treating scapulohumeral periarthritis | |
| CN104758539A (en) | Traditional Chinese medicine composition for treating debilitation | |
| CN104758889A (en) | Traditional Chinese medicine composition for treating diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100519 Termination date: 20120202 |